gvtcx

NHS Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - 1 June 2026

NHS England Published 1 May 2026 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£483,000,001 (£579,600,001 inc. VAT)
Statuscomplete
Category (CPV) 33600000
RegionNorth East, North West, East Midlands, West Midlands, East of England, South East, South West, London, Yorkshire and the Humber
Deadline9 Jan 2026
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-05e360

Awards (26)

This procurement was awarded to 8 suppliers. Values shown are per-award; the notice total is £483,000,001.

SupplierValueDateStatus
Aguettant Ltd shared £171,540,038 27 Feb 2026 pending
Aguettant Ltd shared £87,586,666 27 Feb 2026 pending
Aguettant Ltd shared £19,060,004 27 Feb 2026 pending
Aguettant Ltd shared · · active
Baxter Healthcare Ltd shared £171,540,038 27 Feb 2026 pending
Baxter Healthcare Ltd shared £87,586,666 27 Feb 2026 pending
Baxter Healthcare Ltd shared £30,000,000 27 Feb 2026 pending
Baxter Healthcare Ltd shared £19,060,004 27 Feb 2026 pending
Baxter Healthcare Ltd shared · · active
B. Braun Medical Limited shared £171,540,038 27 Feb 2026 pending
B. Braun Medical Limited shared £87,586,666 27 Feb 2026 pending
B. Braun Medical Limited shared £19,060,004 27 Feb 2026 pending
B. Braun Medical Limited shared · · active
Eleanor Hospital Logistics shared £30,000,000 27 Feb 2026 pending
Eleanor Hospital Logistics shared · · active
Ennogen Healthcare International Limited shared £171,540,038 27 Feb 2026 pending
Ennogen Healthcare International Limited shared £19,060,004 27 Feb 2026 pending
Ennogen Healthcare International Limited shared · · active
Fresenius Kabi Limited shared £171,540,038 27 Feb 2026 pending
Fresenius Kabi Limited shared £19,060,004 27 Feb 2026 pending
Fresenius Kabi Limited shared · · active
Tecrapharm (Germany) GmbH shared £171,540,038 27 Feb 2026 pending
Tecrapharm (Germany) GmbH shared £19,060,004 27 Feb 2026 pending
Tecrapharm (Germany) GmbH shared · · active
THE TPS HEALTHCARE GROUP LIMITED shared £30,000,000 27 Feb 2026 pending
THE TPS HEALTHCARE GROUP LIMITED shared · · active

description

NHS National Proprietary Pharmaceuticals – Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins 1 June 2026 – CM/PHR/25/5727

Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier

CM/PHR/25/5727/02 - Not Regionally Awarded Lines

CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier

CM/PHR/25/5727/04 - Added Value Services

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
18 Nov 2025 Tender notice (UK4) Procurement Act 2023 074790-2025
15 Dec 2025 Tender notice (UK4) Procurement Act 2023 082790-2025
10 Mar 2026 Contract award (UK6) Procurement Act 2023 021422-2026
1 May 2026 Contract details (UK7) Procurement Act 2023 040428-2026

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.